摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,3-二甲基-5-苯基甲氧基苯 | 83619-85-6

中文名称
1,3-二甲基-5-苯基甲氧基苯
中文别名
——
英文名称
1-(benzyloxy)-3,5-dimethylbenzene
英文别名
1-benzyloxy-3,5-dimethylbenzene;Bn-O(C6H3-3,5-Me);1,3-dimethyl-5-phenylmethoxybenzene
1,3-二甲基-5-苯基甲氧基苯化学式
CAS
83619-85-6
化学式
C15H16O
mdl
MFCD21101857
分子量
212.291
InChiKey
IECDCMRAOVTEIO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.1
  • 重原子数:
    16
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    1,3-二甲基-5-苯基甲氧基苯potassium tert-butylate二苯基膦 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 12.0h, 以93%的产率得到3,5-二甲基苯酚
    参考文献:
    名称:
    用 HPPh2 和 tBuOK 对芳基甲基/苄基/烯丙基醚进行脱保护的温和实用方法
    摘要:
    报道了使用 HPPh 2和t BuOK 对芳基醚进行去甲基化、去苄基化和去烯丙基化的通用方法。该反应具有温和且不含金属的反应条件、广泛的底物范围、良好的官能团相容性以及对芳基醚的化学选择性高于脂肪族结构。值得注意的是,这种方法能够选择性地去保护烯丙基或苄基,使其成为有机合成中通用且实用的方法。
    DOI:
    10.1039/d1ob01286j
  • 作为产物:
    描述:
    (1,1'-bis(diphenylphosphino)ferrocene)Pd(benzyl)(OC6H3-3,5-CH3) 在 1,1'-双(二苯基膦)二茂铁 作用下, 以 为溶剂, 反应 7.0h, 以75%的产率得到1,3-二甲基-5-苯基甲氧基苯
    参考文献:
    名称:
    C(sp3)?双键连接的苄基钯(II)芳氧基配合物形成的形成O键的醚的还原性消除作用
    摘要:
    相反:隔离benzylpalladium芳醚络合物经历C(SP 3) O键形成通过逐步离子机制(参见方案)从用于从芳基钯(II)物质的芳族醚的还原消除接受一致途径截然不同的还原消除。提出该机理的原因是芳氧基氧化物配体解离,随后对苄基碳原子的亲核攻击。
    DOI:
    10.1002/anie.201101088
点击查看最新优质反应信息

文献信息

  • Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
    申请人:——
    公开号:US20030065187A1
    公开(公告)日:2003-04-03
    The present invention relates to copper-catalyzed carbon-heteroatom and carbon-carbon bond-forming methods. In certain embodiments, the present invention relates to copper-catalyzed methods of forming a carbon-nitrogen bond between the nitrogen atom of an amide or amine moiety and the activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate. In additional embodiments, the present invention relates to copper-catalyzed methods of forming a carbon-nitrogen bond between a nitrogen atom of an acyl hydrazine and the activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate. In other embodiments, the present invention relates to copper-catalyzed methods of forming a carbon-nitrogen bond between the nitrogen atom of a nitrogen-containing heteroaromatic, e.g., indole, pyrazole, and indazole, and the activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate. In certain embodiments, the present invention relates to copper-catalyzed methods of forming a carbon-oxygen bond between the oxygen atom of an alcohol and the activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate. The present invention also relates to copper-catalyzed methods of forming a carbon-carbon bond between a reactant comprising a nucleophilic carbon atom, e.g., an enolate or malonate anion, and the activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate. Importantly, all the methods of the present invention are relatively inexpensive to practice due to the low cost of the copper comprised by the catalysts.
    本发明涉及铜催化的碳-杂原子和碳-碳键形成方法。在某些实施例中,本发明涉及铜催化的方法,用于在酰胺或胺基团的氮原子与芳基、杂原基或乙烯卤代物或磺酸酯的活化碳之间形成碳-氮键。在其他实施例中,本发明涉及铜催化的方法,用于在酰基肼的氮原子与芳基、杂原基或乙烯卤代物或磺酸酯的活化碳之间形成碳-氮键。在另一些实施例中,本发明涉及铜催化的方法,用于在含氮杂环芳烃(例如吲哚、吡唑和吲哌)的氮原子与芳基、杂原基或乙烯卤代物或磺酸酯的活化碳之间形成碳-氮键。在某些实施例中,本发明涉及铜催化的方法,用于在醇的氧原子与芳基、杂原基或乙烯卤代物或磺酸酯的活化碳之间形成碳-氧键。本发明还涉及铜催化的方法,用于在包含亲核碳原子的反应物(例如烯醇酸盐或丙二酸盐负离子)与芳基、杂原基或乙烯卤代物或磺酸酯的活化碳之间形成碳-碳键。重要的是,由于催化剂中铜的低成本,本发明的所有方法都相对廉价。
  • Copper-Catalyzed <i>N</i>- and <i>O</i>-Alkylation of Amines and Phenols using Alkylborane Reagents
    作者:Shunsuke Sueki、Yoichiro Kuninobu
    DOI:10.1021/ol400323z
    日期:2013.4.5
    in the presence of a catalytic amount of copper(II) acetate Cu(OAc)2 and di-tert-butyl peroxide, a cross-coupling reaction proceeded and alkylated amines were obtained in good to excellent yields. Phenols are also applicable for this reaction, and the corresponding alkyl aryl ethers were produced.
    在催化量的乙酸铜(II)Cu(OAc)2和过氧化二叔丁基的存在下,通过胺与烷基硼烷试剂的反应,进行了交叉偶联反应,得到了烷基化胺,收率良好至极佳。 。酚也可用于该反应,并产生了相应的烷基芳基醚。
  • Use of Tunable Ligands Allows for Intermolecular Pd-Catalyzed C−O Bond Formation
    作者:Andrei V. Vorogushin、Xiaohua Huang、Stephen L. Buchwald
    DOI:10.1021/ja050471r
    日期:2005.6.1
    Pd-catalyzed C-O coupling reactions of aryl halides with primary and secondary alcohols by promoting reductive elimination at the expense of beta-hydride elimination. The key to their success is the ability to match the size of the ligand to that of the combination of substrates. The efficient coupling of a number of unactivated aryl chlorides and bromides with cyclic and acyclic secondary alcohols was achieved
    庞大的联芳基膦配体通过促进还原消除以消除 β-氢化物为代价,促进了 Pd 催化的芳基卤化物与伯醇和仲醇的 CO 偶联反应。它们成功的关键是能够将配体的大小与底物组合的大小相匹配。实现了许多未活化的芳基氯化物和溴化物与环状和非环状仲醇的有效偶联。这包括首次在 Pd 催化的偶联过程中偶联烯丙醇。
  • <i>N</i>,<i>N</i>-Dimethylglycine-Promoted Ullmann-Type Coupling Reactions of Aryl Iodides with Aliphatic Alcohols
    作者:Hui Zhang、Dawei Ma、Weiguo Cao
    DOI:10.1055/s-2007-968010
    日期:2007.2
    The Ullmann-type coupling reactions of aryl iodides and aliphatic alcohols occur at 110 °C with N,N-dimethylglycine as the ligand, giving aryl alkyl ethers in good to excellent yields.
    芳基碘化物和脂肪醇的 Ullmann 型偶联反应在 110 °C 下发生,N,N-二甲基甘氨酸作为配体,产生了良好到极好的收率的芳基烷基醚。
  • Indanylaminopyrazinylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
    申请人:Boehringer Ingelheim International GmbH
    公开号:US20180208560A1
    公开(公告)日:2018-07-26
    The present invention relates to compounds of formula I, wherein the groups R, R 1 , R 2 , R 3 , m and n are defined herein, which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2. Furthermore, the invention relates to novel intermediates, useful for the synthesis of compounds of formula I.
    本发明涉及化合物I的公式,其中R、R1、R2、R3、m和n所定义的基团在此处被定义,具有有价值的药理特性,特别是与GPR40受体结合并调节其活性。这些化合物适用于治疗和预防受这种受体影响的疾病,如代谢性疾病,特别是2型糖尿病。此外,该发明涉及用于合成化合物I的新型中间体。
查看更多